Skip to main content
. 2016 Feb 23;2016:4792898. doi: 10.1155/2016/4792898

Table 2.

Current steroid use Steroid in prior 6 months Maintenance Therapy
Anti-TNF based therapy Immunomodulator Monotherapy
(AZA or MTX)
5-ASA/
sulfasalazine
Other None
CD 3% 8% 61% 27% 6% 1% 5%
UC 10% 21% 31% 21% 36% 1% 11%

indicates CD versus UC, p < 0.05.